BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25631034)

  • 1. Characterization of mitochondrial populations during stem cell differentiation.
    Kerscher P; Bussie BS; DeSimone KM; Dunn DA; Lipke EA
    Methods Mol Biol; 2015; 1264():453-63. PubMed ID: 25631034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial development of the in vitro hepatic organogenesis model with simultaneous cardiac mesoderm differentiation from murine induced pluripotent stem cells.
    Tamai M; Yamashita A; Tagawa Y
    J Biosci Bioeng; 2011 Nov; 112(5):495-500. PubMed ID: 21816670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CytoSpectre: a tool for spectral analysis of oriented structures on cellular and subcellular levels.
    Kartasalo K; Pölönen RP; Ojala M; Rasku J; Lekkala J; Aalto-Setälä K; Kallio P
    BMC Bioinformatics; 2015 Oct; 16():344. PubMed ID: 26503371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal analysis and classification methods for the calcium transient data of stem cell-derived cardiomyocytes.
    Juhola M; Penttinen K; Joutsijoki H; Varpa K; Saarikoski J; Rasku J; Siirtola H; Iltanen K; Laurikkala J; Hyyrö H; Hyttinen J; Aalto-Setälä K
    Comput Biol Med; 2015 Jun; 61():1-7. PubMed ID: 25841082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scalable production of cardiomyocytes derived from c-Myc free induced pluripotent stem cells.
    Zwi-Dantsis L; Mizrahi I; Arbel G; Gepstein A; Gepstein L
    Tissue Eng Part A; 2011 Apr; 17(7-8):1027-37. PubMed ID: 21087204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen consumption of human heart cells in monolayer culture.
    Sekine K; Kagawa Y; Maeyama E; Ota H; Haraguchi Y; Matsuura K; Shimizu T
    Biochem Biophys Res Commun; 2014 Sep; 452(3):834-9. PubMed ID: 25218502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mytoe: automatic analysis of mitochondrial dynamics.
    Lihavainen E; Mäkelä J; Spelbrink JN; Ribeiro AS
    Bioinformatics; 2012 Apr; 28(7):1050-1. PubMed ID: 22321700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of physiological matrix conditions on permanent culture of induced pluripotent stem cell-derived cardiomyocytes.
    Heras-Bautista CO; Katsen-Globa A; Schloerer NE; Dieluweit S; Abd El Aziz OM; Peinkofer G; Attia WA; Khalil M; Brockmeier K; Hescheler J; Pfannkuche K
    Biomaterials; 2014 Aug; 35(26):7374-85. PubMed ID: 24889032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTRIP: an imaging tool to investigate mitochondrial DNA dynamics in physiology and disease at the single-cell resolution.
    Chatre L; Ricchetti M
    Methods Mol Biol; 2015; 1264():133-47. PubMed ID: 25631010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.
    Prigione A; Fauler B; Lurz R; Lehrach H; Adjaye J
    Stem Cells; 2010 Apr; 28(4):721-33. PubMed ID: 20201066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of a purification and expansion method for human embryonic stem cell-derived cardiomyocytes.
    Park SJ; Bae D; Moon SH; Chung HM
    Cardiology; 2013; 124(3):139-50. PubMed ID: 23428747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of arrhythmic potential of embryonic stem cell-derived cardiomyocytes.
    Shang LL; Dudley SC; Pfahnl AE
    Methods Mol Biol; 2006; 330():221-31. PubMed ID: 16846027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening.
    Rana P; Anson B; Engle S; Will Y
    Toxicol Sci; 2012 Nov; 130(1):117-31. PubMed ID: 22843568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Automated High-Content Analysis Workflow Capturing Cell Population Dynamics from Induced Pluripotent Stem Cell Live Imaging Data.
    Kerz M; Folarin A; Meleckyte R; Watt FM; Dobson RJ; Danovi D
    J Biomol Screen; 2016 Oct; 21(9):887-96. PubMed ID: 27256155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization.
    He JQ; Ma Y; Lee Y; Thomson JA; Kamp TJ
    Circ Res; 2003 Jul; 93(1):32-9. PubMed ID: 12791707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation pathways in human embryonic stem cell-derived cardiomyocytes.
    Lev S; Kehat I; Gepstein L
    Ann N Y Acad Sci; 2005 Jun; 1047():50-65. PubMed ID: 16093484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria determine the differentiation potential of cardiac mesoangioblasts.
    San Martin N; Cervera AM; Cordova C; Covarello D; McCreath KJ; Galvez BG
    Stem Cells; 2011 Jul; 29(7):1064-74. PubMed ID: 21544900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial function in pluripotent stem cells and cellular reprogramming.
    Bukowiecki R; Adjaye J; Prigione A
    Gerontology; 2014; 60(2):174-82. PubMed ID: 24281332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.